DNA damage response genes as biomarkers of therapeutic outcomes in acute myeloid leukemia patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
DNA damage response genes as biomarkers of therapeutic outcomes in acute myeloid leukemia patients ; volume:38 ; number:6 ; day:11 ; month:5 ; year:2024 ; pages:1407-1410 ; date:6.2024
Leukemia ; 38, Heft 6 (11.5.2024), 1407-1410, 6.2024
- Urheber
-
Karami, Adam
Skorski, Tomasz
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-024-02269-9
- URN
-
urn:nbn:de:101:1-2408102104294.264882797382
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karami, Adam
- Skorski, Tomasz
- SpringerLink (Online service)
Ähnliche Objekte (12)
OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Therapeutic use of Aldara™ in chronic myeloid leukemia
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Detecting the stable point of therapeutic effect of chronic myeloid leukemia based on dynamic network biomarkers
RhoA: A therapeutic target for chronic myeloid leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia
Multiple machine-learning tools identifying prognostic biomarkers for acute Myeloid Leukemia
OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Therapeutic use of Aldara™ in chronic myeloid leukemia
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Detecting the stable point of therapeutic effect of chronic myeloid leukemia based on dynamic network biomarkers
RhoA: A therapeutic target for chronic myeloid leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia
Multiple machine-learning tools identifying prognostic biomarkers for acute Myeloid Leukemia
OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine
Novel Therapeutic Targets in Acute Myeloid Leukemia (AML)
Immune-Based Therapeutic Strategies for Acute Myeloid Leukemia
Therapeutic use of Aldara™ in chronic myeloid leukemia
Chronic myeloid leukemia stem cells: targeting therapeutic implications
Detecting the stable point of therapeutic effect of chronic myeloid leukemia based on dynamic network biomarkers
RhoA: A therapeutic target for chronic myeloid leukemia
Therapeutic strategies to improve treatment outcome in acute myeloid leukemia
Mechanistic and therapeutic insights into IDH1 mutant acute myeloid leukemia
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
Glutamine synthetase : a potential therapeutic target in acute myeloid leukemia